Biotechnology Stocks II Performance Guide: Oculis Holding AG (OCS)
OCS has no dividends.
Table and Chart of OCS Performance
See what a $1,000 investment in OCS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| OCS Returns | |
|---|---|
| Start Date | Apr-28-2023 |
| Start Price | $11.13 |
| End Date | Jul-26-2024 |
| End Price | $11.63 |
| # Prices | 16 |
| Min Date | Oct-31-2023 |
| Min Price | $9.80 |
| Max Date | Aug-31-2023 |
| Max Price | $13.10 |
| Total Return | 4.45% |
| Annualized Return | 3.32% |
| Current Value of $1,000 Purchase | $1,044 |
| Number Returns | 120 |
| Average Return | 2.35% |
| Number Profitable Returns | 67 |
| Percent Profitable Returns | 55.83% |
| Number Unprofitable Returns | 53 |
| Percent Unprofitable Returns | 44.17% |
| Profitable to Unprofitable Returns Ratio | 1.26 |
| OCS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $539,908,000 |
| Beta | 0.082 | Price to Sales | 496.20 |
| Earnings per Share | $0.1800 |
| PE Ratio | 64.58 |
| PE to Growth Ratio | None |
| Price to Book | 4.285 |
| PRICE DATA | |
| 52 Week High | $14.5 |
| 52 Week Low | $9.05 |
| Analyst Target Price | $28.72 |
| 50-Day Moving Average | $11.76 |
| 200-Day Moving Average | $11.43 |
| FINANCIAL DATA | |
| Revenue per Share | $0.024 |
| Revenue | $876,000 |
| Profit Margin | 0% |
| Return on Equity | -1026% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
OCS Compare Returns with S&P 500
OCS Trendline Chart
OCS Moving Average Chart
OCS Stock Return Map - See Patterns of Gains and Losses
OCS Stock Returns/Purchase Dates